Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.26M Sell
10,503
-1,313
-11% -$152K 0.56% 52
2025
Q4
$1.24M Sell
11,816
-279
-2% -$26.2K 0.42% 63
2025
Q3
$1.02M Buy
12,095
+176
+1% +$14.5K 0.33% 66
2025
Q2
$944K Sell
11,919
-1,616
-12% -$128K 0.33% 66
2025
Q1
$1.21M Buy
13,535
+27
+0.2% +$2.52K 0.45% 69
2024
Q4
$1.34M Sell
13,508
-13
-0.1% -$1.34K 0.44% 67
2024
Q3
$1.54M Buy
13,521
+80
+0.6% +$9.5K 0.51% 61
2024
Q2
$1.66M Buy
13,441
+26
+0.2% +$3.35K 0.6% 57
2024
Q1
$1.77M Buy
+13,415
New +$1.65M 0.71% 50

Other funds holding MRK

NIA Impact Advisors's MRK Position: Q1 2026 in Review

NIA Impact Advisors reduced its Merck (MRK) stake by 11% in Q1 2026, selling an estimated $152K and leaving 10,503 shares worth $1.26M. The position accounts for 0.56% of the portfolio, ranked #52.

NIA Impact Advisors first reported a position in MRK in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.77M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • NIA Impact Advisors held 10,503 shares of Merck worth $1.26M as of Q1 2026.
  • NIA Impact Advisors sold 1,313 Merck shares in Q1 2026, an estimated $152K.
  • Merck made up 0.56% of NIA Impact Advisors's portfolio in Q1 2026, its #52 holding.
  • NIA Impact Advisors first reported a position in Merck in Q1 2024 and has held it in 9 quarters since.
  • NIA Impact Advisors's Merck position peaked at $1.77M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on NIA Impact Advisors's 13F filing for Q1 2026, filed 8 May 2026.